• Fri, November 11, 2022

Yatin Suneja Maintained (XENE) at Strong Buy with Decreased Target to $49 on, Nov 11th, 2022

Yatin Suneja of Guggenheim, Maintained "Xenon Pharmaceuticals Inc." (XENE) at Strong Buy with Decreased Target from $53 to $49 on, Nov 11th, 2022.

Yatin has made no other calls on XENE in the last 4 months.



There are 5 other peers that have a rating on XENE. Out of the 5 peers that are also analyzing XENE, 0 agree with Yatin's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Yatin


  • Danielle Brill of "Raymond James" Initiated at Buy and Held Target at $52 on, Wednesday, October 19th, 2022
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $49 on, Tuesday, October 11th, 2022
  • Jason Gerberry of "B of A Securities" Initiated at Strong Buy on, Monday, August 29th, 2022
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $46 on, Thursday, August 11th, 2022
  • Tessa Romero of "JP Morgan" Initiated at Buy and Held Target at $55 on, Thursday, July 21st, 2022

Like: 👍